|
|
|
Volumn 40, Issue 1034, 1998, Pages 87-
|
|
Risedronate for Paget's disease of bone
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
ALUMINUM;
CALCITONIN;
CALCIUM;
ETIDRONIC ACID;
MAGNESIUM;
PAMIDRONIC ACID;
RISEDRONIC ACID;
TILUDRONIC ACID;
BONE ATROPHY;
BONE MALFORMATION;
BONE MINERALIZATION;
BONE TURNOVER;
CLINICAL TRIAL;
CONTROLLED STUDY;
DIET RESTRICTION;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
HUMAN;
MAJOR CLINICAL STUDY;
OSTEOPOROSIS;
PAGET BONE DISEASE;
REVIEW;
ADMINISTRATION, ORAL;
AGED;
BONE RESORPTION;
CALCIUM CHANNEL BLOCKERS;
CLINICAL TRIALS;
DIARRHEA;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
ESOPHAGITIS;
ETIDRONIC ACID;
HUMANS;
INTESTINAL ABSORPTION;
MIDDLE AGED;
NAUSEA;
OSTEITIS DEFORMANS;
|
|
EID: 0032575720
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (8)
|
